PREVIEW | CONFIDENTIAL | BY INVITATION ONLY
BREAKING SCIENCE INTO SPORT
BY ATHLETES & SCIENTISTS | FOR GENERATIONS
invest where athletes don't just play — they lead, invest, and deploy capital directly into human performance science.
The market has never brought scientific rigor to the biology of competitiveness. The athletes who prove that science out every single day have rarely had a seat as its owners.
Angela Ruggiero and Sans Thakur, backed by TOWER Capital Group, are building the vehicle to change that.
$2 Trillion. 97% Not on Human Health. One Fund Fixes It.
Every year, trillions of dollars pour into sport. But not the biology that fuels it. 97% of investments go to jerseys, stadiums, and media. Almost none funds the one thing athletes' own bodies have already proven works: the science of recovery, brain health, and longevity.
The Generational Sports Science Fund closes that gap.
Collisions of longevity biotechnology + sports, amplified by women
BREAKING SCIENCE INTO SPORT
The math starts at $2 trillion. That's the combined addressable market sitting at the intersection of sports with cutting edge science: digital health and AI ($900B–$1.2T), brain and family health ($880B), AI compute infrastructure ($300B–$600B), genomics ($55B–$60B), and longevity science ($30B–$50B) — and it's all layered on top of a population in need: 1.7 billion people worldwide living with musculoskeletal conditions.
Amplified by the TOWER edge in science
1,000+ vetted innovations already in the dealbook
$28B+ in networked TOWER's Generational Health dealbook
Operating leadership across 5 continents
175+ years of combined experience
40+ sciences launched to date
DRIVEN by athletes
The hardest stress-test human performance science will ever face. This fund turns that demand into deployable capital — in a category the market has structurally starved of investment. This further amped by the massive growth of the female athletic markets and our understanding of the underlying biology that fuels them.
The elite athlete | SCIENTIST | INVESTOR
DEMAND, DESIGN & ELITE EXECUTION
Explosive, Investable Demand: Elite athletes are willing, motivated, biologically extreme test cases for performance science. Women's sport is growing 300% — and amplified by life sciences/tech-- the fastest-growing intersection. Where, demand for longevity and biotech is no longer observable. It's investable.
Lean & Scalable by Design: A tiered athlete-engagement model — scales trust and access without diluting fund discipline. Zero minimum investment to vote or advise. Full LP rights for those who invest. Honoring athletes lived experience and ability to be owners and actors in the business.
Elite Execution: Angela Ruggiero won Olympic gold, was inducted into the Hockey Hall of Fame, sat on the IOC's Executive Board, and now serves as Chief Strategy Officer for the 2028 LA Olympics. Sans Thakur architected a $1.3 trillion scientific-asset model, executed in multiple unicorns, and has spent 25 years growing health-science and technology. Together, that's a combination of athlete credibility and capital discipline the market has never seen paired at this level.
MEET THE FOUNDERS
ANGELA
SANS
Angela Ruggiero: Olympic Gold Medalist. Named to Forbes's “25 Most Powerful Women in Sport." Co-founded and chairs Sports Innovation Lab. Leads the Women's Sports Club. Co-founded 4TheWalk. Eight years on the IOC's Executive Board. Chief Strategy Officer for the 2028 LA Olympics. Advisor to the Boston Athletic Association, International Ice Hockey Federation, and World Rugby. 4th woman inducted into the Hockey Hall of Fame. Four-time Olympian. Harvard MBA. Wharton PE certificate.
Sans Thakur: The global pioneer of Generational Health. 25 years in health-science and technology. Directed multi-billion-dollar portfolios. World Economic Forum Healthcare and Longevity Council leader. UN Population Fund strategic partner. Supported anearly company 300%+ to double-unicorn status as Chief Growth Officer. Led Accenture's global life sciences practice across 24 markets. Author of New Science. Modeled $1.3T in scientific assets. Led the life-science COVID-19 response, assessing 50,000+ innovations. Ran $9B in pharma strategy at Boehringer Ingelheim.
Angela brings operator grit with athlete trust, network, and lived understanding of elite performance. Sans brings innovator and capital discipline, scientific infrastructure, and a Generational Health record. — together they move at the speed of real athlete relationships while investing with rigor. Neither could build this alone.
structural not symbolic: Athletes as owners & invesTors
The commitment to athletes is built in three layers, and none of them require writing a check to matter.
The Voting Board:
Up to five athletes who vote on and steer investment decisions directly from lived experience, sitting in on quarterly investment committee reviews with real operator and investor privileges, at no cost to join.
The Advisor Team:
A group of five to ten athletes, coaches, and sports-science leaders who advise portfolio company boards and act as market and fund specialists, engaging biannually with the option to join monthly innovator sessions — also free.
The Athlete Limited Partner:
And for any athlete who wants to go further, there's a third tier: Athletes as Investors, open to anyone who wants full LP rights, with a $250,000 minimum to participate.
VELOCITY & PROJECTIONS
A Thesis of Differentiated Returns through Athlete & Scientific Strategy
Trillions flow into sport annually; almost none funds the science that drives human performance.
Yet, Life sciences has consistently outperformed traditional sports investing — Directing capital into life-sciences-grade assets within the sports category captures that premium while benefiting from sport's own growth trajectory.
This is the arbitrage: a return profile the market has not yet priced, absent a vehicle built to capture it. Execution is grounded in existing infrastructure: 1,000+ vetted innovations, $28B+ in networked assets, 175+ years of combined experience, and 40+ medicines launched to date — paired with unmatched athlete access and trust. Expected outcome: life-sciences-grade IRR at sports-sector speed.
Life sciences beats sports investing — on cash, not just paper. Historically, life sciences funds return 1.14x DPI to LPs vs. 1.02x for the broader VC market, and 11.5% of biopharma deals hit a >5x return vs. 9.8% in software. Our own analogs show 5.1x–6.8x across verticals. Pair that return profile with the growth and innovation cycle of sport, and you get the fund's premium.
FUND STRUCTURE
Generational Sports Fund I, LP — closed-end, 10-year vehicle focused on scalable science in sport across early to mid stage innovative companies.
Carry: 80% LPs / 20% GP
General Partner: Angela Ruggiero & Sans Thakur with Athlete Partner and powered by TOWER the pioneer of Generational health
Anchor LP Minimum: $25M
Target Raise: $500M where TOWER holds a Generational Health premium.
Deployment: 1–3 year deployment window per asset, staged across the portfolio, disbursements concentrated in years 3-7.
Portfolio Mechanics:
25-30 investments in Series A and B companies
Check size between 5M - 25M, with discretion
Co-investment rights secured for priority LPs and family offices
PREMIUM OUTCOMES & PROJECTIONS
The co-founding of elite athlete with successful science of our portfolio analogs with a health-science backbone for sport that reflect 5.1x–6.8x across category. Pair that return profile with the growth and innovation cycle of sport, and you get the fund's premium.
Sports Focus: Training, Health Management, Recovery, Rehabilitation, Performance Longevity
Science Focus: Disease Prevention & Cure, Health Optimization above Baseline, Bionic Self, and Future of Longevity Innovations
invest where athletes don't just play — they lead, invest, and deploy capital directly into human performance science.
LED by Angela Ruggiero and Sans Thakur
built on TOWER Capital Group, the pioneer of Generational Health.
